Dylan Morris

Voorzitter bij

Vecprobio Inc.

Health Technology

Technology Services

Finance

Profiel

Dylan Morris is the founder of Integrated Plasmonics Corp., founded in 2011.
Current jobs include Chairman at Vecprobio Inc., Managing Director at Insight Venture Management LLC since 2021, Director at Deciduous Therapeutics, Inc., Director at Dyno Therapeutics, Inc., Director at Unlearn.ai, Inc. since 2022, Board Of Director at Gameto, Inc. since 2022, Director at ArrePath, Inc., Board Of Director at ImmuneBridge, Inc. since 2023, Board Of Director at DEM BioPharma, Inc. since 2022, Board Of Director at Capacity Bio, Inc. since 2022, Board Of Director at Superluminal Medicines, Inc. since 2023, and Board Of Directot at Switch Therapeutics, Inc. since 2020.
Former job includes General Partner at CRV LLC from 2017 to 2021.

Actieve functies van Dylan Morris

Bedrijven	Functie	Begin
Deciduous Therapeutics, Inc. Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism	Directeur/Bestuurslid	-
Dyno Therapeutics, Inc. Dyno Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a biotechnology company that uses artificial intelligence for gene therapy	Directeur/Bestuurslid	-
Unlearn.AI, Inc. Unlearn.AI, Inc. Packaged SoftwareTechnology Services Develops an AI-powered platform that generates digital twins to simulate and optimize clinical trials in medicine	Directeur/Bestuurslid	19-04-2022
ArrePath, Inc. ArrePath, Inc. BiotechnologyHealth Technology Develops molecular therapeutics and provides AI & machine learning technology services in the field of drug discovery	Directeur/Bestuurslid	-
Vecprobio Inc. Vecprobio Inc. Packaged SoftwareTechnology Services Develops manufacturing technologies and tools for gene therapy	Voorzitter	-
Insight Venture Management LLC Insight Venture Management LLC Investment ManagersFinance Insight Partners invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early, later and growth stage capital requirements.	Private Equity Investor	01-01-2021
Switch Therapeutics, Inc. Switch Therapeutics, Inc. BiotechnologyHealth Technology Develops RNAi research for therapeutic applications	Directeur/Bestuurslid	01-01-2020
DEM BioPharma, Inc. DEM BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that manufactures cancer therapeutics	Directeur/Bestuurslid	01-01-2022
Capacity Bio, Inc. Capacity Bio, Inc. BiotechnologyHealth Technology Engages in targeting fundamental biology for radical therapeutic benefits	Directeur/Bestuurslid	01-01-2022
░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░░░░░░	░░░░░░░░░░

Alle actieve functies van Dylan Morris

Eerdere bekende functies van Dylan Morris

Bedrijven	Functie	Einde
░░░ ░░░	░░░░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░ ░░░░░	░░░░░░░░░	░░░░░░░░░░

Ervaring van Dylan Morris in detail bekijken

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Dylan Morris in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	14
Integrated Plasmonics Corp. Integrated Plasmonics Corp. SemiconductorsElectronic Technology Develops and manufactures integrated plasmonic surface-sensing devices for spectrographically examine biochemical samples	Electronic Technology
Insight Venture Management LLC Insight Venture Management LLC Investment ManagersFinance Insight Partners invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for early, later and growth stage capital requirements.	Finance
CRV LLC CRV LLC Investment ManagersFinance Charles River Ventures invests in companies located in the United States. The firm focuses on communications & technology, enterprise software/services and media/entertainment sectors. It provides financing for seed and early stage capital requirements with an investment size of $ 0.025 to 5 million. It acts as the lead investor.	Finance
Deciduous Therapeutics, Inc. Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for immune mechanism	Health Technology
Dyno Therapeutics, Inc. Dyno Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a biotechnology company that uses artificial intelligence for gene therapy	Technology Services
Unlearn.AI, Inc. Unlearn.AI, Inc. Packaged SoftwareTechnology Services Develops an AI-powered platform that generates digital twins to simulate and optimize clinical trials in medicine	Technology Services
Switch Therapeutics, Inc. Switch Therapeutics, Inc. BiotechnologyHealth Technology Develops RNAi research for therapeutic applications	Health Technology
Gameto, Inc. Gameto, Inc. BiotechnologyHealth Technology Develops biotechnologies in female reproductive solutions	Health Technology
ImmuneBridge, Inc. ImmuneBridge, Inc. BiotechnologyHealth Technology Develops allogeneic immunotherapies for cancer	Health Technology
ArrePath, Inc. ArrePath, Inc. BiotechnologyHealth Technology Develops molecular therapeutics and provides AI & machine learning technology services in the field of drug discovery	Health Technology
DEM BioPharma, Inc. DEM BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that manufactures cancer therapeutics	Commercial Services
Capacity Bio, Inc. Capacity Bio, Inc. BiotechnologyHealth Technology Engages in targeting fundamental biology for radical therapeutic benefits	Health Technology
Vecprobio Inc. Vecprobio Inc. Packaged SoftwareTechnology Services Develops manufacturing technologies and tools for gene therapy	Technology Services
Superluminal Medicines Inc Superluminal Medicines Inc BiotechnologyHealth Technology Operates as a generative biological and chemical company	Health Technology